An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called orforglipron, demonstrated “meaningful weight loss” and cardiometabolic improvements, according to a press release. The phase 3 ATTAIN-1 trial, which was …
Read More »New breast cancer drug wins FDA approval after slashing progression risk by nearly 40%
The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to treat adults with specific types of the disease. Those types include estrogen receptor-positive (ER+), human epidermal growth factor receptor …
Read More »Growing antibiotic crisis could turn bacterial infections deadly, experts warn
As “superbugs” continue to surge, the World Health Organization is now warning that one in every six bacterial infections are resistant to antibiotics. WHO also called for antibiotic medications to be used more responsibly, according to a press release published by the agency on Monday. Based on data from more …
Read More »Hair-loss drug tied to suicides, depression and anxiety in global study
This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255). Millions of men undergoing hair loss treatment may be putting their mental health on the line. Finasteride, a hair-loss drug prescribed for androgenetic …
Read More »Low testosterone signs men can’t ignore — and what experts say about hormone therapy
A recent episode of the hit Hulu comedy “Only Murders in the Building” highlights a hormone therapy that many men request as they get older. Steve Martin’s character, Charles-Haden Savage — a washed-up actor who gets a second career solving murders in his apartment building — brags of his newfound …
Read More »Experts sound alarm as weight-loss shortcut could put Americans at risk
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as …
Read More »Weight-loss surgery pros and cons in the spotlight after singer's 'scary' experience
Amid the surge in GLP-1 weight-loss medications, some have questioned whether invasive procedures like lap band, gastric sleeve and bypass surgeries could wane in popularity. Carnie Wilson, of the band Wilson Phillips, recently shared her “very scary” experience on social media after having her laparoscopic adjustable gastric band (lap band) …
Read More »Ozempic and similar drugs could interfere with common medical procedure, research warns
Researchers have revealed a surprising new side effect linked to GLP-1 agonists, such as Ozempic, Wegovy, Mounjaro and Zepbound. These popular treatments for diabetes and obesity could interfere with medical imaging, such as PET and CT (“CAT”) scans. CT scans are often used to get detailed internal images to detect …
Read More »Paralyzed man walks again after experimental drug trial triggers remarkable recovery
An experimental drug could help to improve movement for patients with spinal cord injuries. NVG-291, an injectable peptide, has been tested in a phase 2 trial with eligible patients — some of whom noted remarkable outcomes. Larry Williams, a trial participant based in Philadelphia, Pennsylvania, shared with Fox News Digital …
Read More »Scientists may have discovered first gene therapy for incurable brain disease
Scientists may have discovered the first therapy for Huntington’s disease, a brain disorder that until now has had no effective treatments. Researchers at the University of College London (UCL) announced positive results from a global clinical trial for a new gene therapy, AMT-130. Developed by the Dutch biotechnology company uniQure, …
Read More »